Young Dogs With Splenic Cancer Live Far Longer on Chemotherapy, Landmark Trial Reveals
A phase I trial of propranolol plus doxorubicin found no survival benefit from the beta-blocker, but revealed that young adult ...
Tag: canine hemangiosarcoma
DNA Repair Protein Fails to Explain Why a Common Dog Cancer Shrugs Off Chemotherapy Drug
New laboratory research shows that canine hemangiosarcoma cell lines resist the chemotherapy drug temozolomide through a mechanism independent of the ...
RNA Profiling Splits Deadly Dog Spleen Cancer into Three Actionable Subtypes
Researchers at the University of São Paulo used a qPCR-based gene expression panel to divide canine splenic hemangiosarcoma into three ...
Breakthrough Research on Lethal Canine Cancer Uncovers Pathways for Enhanced Treatment
Researchers at the University of Florida College of Veterinary Medicine, in collaboration with the UF Health Cancer Center, have made ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!